{
    "relation": [
        [
            "Feature key",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti",
            "Describes natural variant(s) of the protein sequence.More...Natural varianti"
        ],
        [
            "Position(s)",
            "25 \u2013 25",
            "39 \u2013 39",
            "127 \u2013 127",
            "127 \u2013 127",
            "166 \u2013 166",
            "170 \u2013 170",
            "170 \u2013 170",
            "178 \u2013 178",
            "178 \u2013 178",
            "178 \u2013 178",
            "180 \u2013 180",
            "192 \u2013 192",
            "196 \u2013 196",
            "197 \u2013 197",
            "200 \u2013 200",
            "204 \u2013 204",
            "210 \u2013 210",
            "211 \u2013 211",
            "226 \u2013 226",
            "247 \u2013 247",
            "249 \u2013 249",
            "250 \u2013 250",
            "250 \u2013 250",
            "252 \u2013 252",
            "252 \u2013 252",
            "258 \u2013 258",
            "269 \u2013 269",
            "269 \u2013 269",
            "279 \u2013 279",
            "293 \u2013 293",
            "295 \u2013 295",
            "301 \u2013 301",
            "304 \u2013 304",
            "314 \u2013 314",
            "320 \u2013 320",
            "335 \u2013 335",
            "347 \u2013 352",
            "391 \u2013 391",
            "399 \u2013 399",
            "420 \u2013 420",
            "436 \u2013 436",
            "454 \u2013 454",
            "455 \u2013 455",
            "458 \u2013 458",
            "474 \u2013 474",
            "482 \u2013 482",
            "484 \u2013 484",
            "485 \u2013 485",
            "499 \u2013 499",
            "499 \u2013 499",
            "504 \u2013 504",
            "504 \u2013 504"
        ],
        [
            "Length",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "6",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1",
            "1"
        ],
        [
            "Description",
            "P \u2192 S in GM2G1; late infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.31 \"Two new mutations in a late infantile Tay-Sachs patient are both in exon 1 of the beta-hexosaminidase alpha subunit gene.\" Harmon D.L., Gardner-Medwin D., Stirling J.L. J. Med. Genet. 30:123-128(1993) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 SER-25.",
            "L \u2192 R in GM2G1; infantile.",
            "L \u2192 F in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.38 \"Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.\" Akerman B.R., Natowicz M.R., Kaback M.M., Loyer M., Campeau E., Gravel R.A. Am. J. Hum. Genet. 60:1099-1106(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-127; PHE-226; ASP-269 AND VAL-314.",
            "L \u2192 R in GM2G1; infantile.",
            "R \u2192 G in GM2G1; late infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.35 \"GM2 gangliosidosis B1 variant: biochemical and molecular characterization of hexosaminidase A.\" Peleg L., Meltzer F., Karpati M., Goldman B. Biochem. Mol. Med. 54:126-132(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 GLY-166.",
            "R \u2192 Q in GM2G1; infantile; inactive or unstable protein. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.39 \"Tay-Sachs disease and HEXA mutations among Moroccan Jews.\" Kaufman M., Grinshpun-Cohen J., Karpati M., Peleg L., Goldman B., Akstein E., Adam A., Navon R. Hum. Mutat. 10:295-300(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 GLN-170; PHE-304 DEL AND LYS-482.",
            "R \u2192 W in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.26 \"A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation.\" Fernandes M., Kaplan F., Natowicz M., Prence E., Kolodny E., Kaback M., Hechtman P. Hum. Mol. Genet. 1:759-761(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 TRP-170 AND HIS-258.",
            "R \u2192 C in GM2G1; infantile; inactive protein.",
            "R \u2192 H in GM2G1; infantile; inactive protein.",
            "R \u2192 L in GM2G1; infantile. Corresponds to variant rs28941770 [ dbSNP | Ensembl ].",
            "Y \u2192 H in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.37 \"Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180-->His) in the Hex A alpha-chain gene.\" de Gasperi R., Gama Sosa M.A., Battistini S., Yeretsian J., Raghavan S., Zelnik N., Leshinsky E., Kolodny E.H. Neurology 47:547-552(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 HIS-180. Corresponds to variant rs28941771 [ dbSNP | Ensembl ].",
            "V \u2192 L in GM2G1; infantile.",
            "N \u2192 S in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.34 \"Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.\" Triggs-Raine B.L., Richard M., Wasel N., Prence E.M., Natowicz M.R. Am. J. Hum. Genet. 56:870-879(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 SER-196 AND SER-250.",
            "K \u2192 T in GM2G1.",
            "V \u2192 M in GM2G1. Corresponds to variant rs1800429 [ dbSNP | Ensembl ].",
            "H \u2192 R in GM2G1; infantile.",
            "S \u2192 F in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.23 \"Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.\" Akli S., Lacorte J.-M., Poenaru L., Khan A. Genomics 11:124-134(1991) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-210 AND CYS-504.",
            "F \u2192 S in GM2G1; infantile.",
            "S \u2192 F in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.38 \"Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.\" Akerman B.R., Natowicz M.R., Kaback M.M., Loyer M., Campeau E., Gravel R.A. Am. J. Hum. Genet. 60:1099-1106(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-127; PHE-226; ASP-269 AND VAL-314.",
            "R \u2192 W in HEXA pseudodeficiency. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.25 \"A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.\" Triggs-Raine B.L., Mules E.H., Kaback M.M., Lim-Steele J.S.T., Dowling C.E., Akerman B.R., Natowicz M.R., Grebner E.E., Navon R., Welch J.P., Greenberg C.R., Thomas G.H., Gravel R.A. Am. J. Hum. Genet. 51:793-801(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PSEUDODEFICIENCY TRP-247. Corresponds to variant rs121907970 [ dbSNP | Ensembl ].",
            "R \u2192 W in HEXA pseudodeficiency. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.6 \"The full-ORF clone resource of the German cDNA consortium.\" Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS PSEUDODEFICIENCY TRP-249 AND VAL-436. Ref.29 \"A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.\" Cao Z., Natowicz M.R., Kaback M.M., Lim-Steele J.S.T., Prence E.M., Brown D., Chabot T., Triggs-Raine B.L. Am. J. Hum. Genet. 53:1198-1205(1993) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PSEUDODEFICIENCY TRP-249.",
            "G \u2192 D in GM2G1; juvenile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.27 \"A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.\" Trop I., Kaplan F., Brown C., Mahuran D., Hechtman P. Hum. Mutat. 1:35-39(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 ASP-250.",
            "G \u2192 S in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.34 \"Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.\" Triggs-Raine B.L., Richard M., Wasel N., Prence E.M., Natowicz M.R. Am. J. Hum. Genet. 56:870-879(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 SER-196 AND SER-250.",
            "R \u2192 H in GM2G1.",
            "R \u2192 L in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.43 \"Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.\" Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T. J. Hum. Genet. 48:571-574(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499.",
            "D \u2192 H in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.26 \"A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation.\" Fernandes M., Kaplan F., Natowicz M., Prence E., Kolodny E., Kaback M., Hechtman P. Hum. Mol. Genet. 1:759-761(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 TRP-170 AND HIS-258.",
            "G \u2192 D in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.38 \"Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.\" Akerman B.R., Natowicz M.R., Kaback M.M., Loyer M., Campeau E., Gravel R.A. Am. J. Hum. Genet. 60:1099-1106(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-127; PHE-226; ASP-269 AND VAL-314.",
            "G \u2192 S in GM2G1; late onset; inhibited subunit dissociation. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.21 \"The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease.\" Navon R., Proia R.L. Science 243:1471-1474(1989) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 SER-269.",
            "S \u2192 P in GM2G1; late infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.41 \"Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.\" Drucker L., Hemli J.A., Navon R. Hum. Mutat. 10:451-457(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 PRO-279.",
            "S \u2192 I. Corresponds to variant rs1054374 [ dbSNP | Ensembl ].",
            "N \u2192 S in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.43 \"Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.\" Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T. J. Hum. Genet. 48:571-574(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499. Corresponds to variant rs199578185 [ dbSNP | Ensembl ].",
            "M \u2192 R in GM2G1; infantile.",
            "Missing in GM2G1; infantile; Moroccan Jewish. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.39 \"Tay-Sachs disease and HEXA mutations among Moroccan Jews.\" Kaufman M., Grinshpun-Cohen J., Karpati M., Peleg L., Goldman B., Akstein E., Adam A., Navon R. Hum. Mutat. 10:295-300(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 GLN-170; PHE-304 DEL AND LYS-482.",
            "D \u2192 V in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.38 \"Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.\" Akerman B.R., Natowicz M.R., Kaback M.M., Loyer M., Campeau E., Gravel R.A. Am. J. Hum. Genet. 60:1099-1106(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-127; PHE-226; ASP-269 AND VAL-314.",
            "Missing in GM2G1; late infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.24 \"Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.\" Mules E.H., Hayflick S., Miller C.S., Reynolds L.W., Thomas G.H. Am. J. Hum. Genet. 50:834-841(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 GLY-320 DEL, VARIANTS ASP-399 AND VAL-436.",
            "I \u2192 F in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.32 \"Three novel beta-hexosaminidase A mutations in obligate carriers of Tay-Sachs disease.\" Tomczak J., Grebner E.E. Hum. Mutat. 4:71-72(1994) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-335 AND 347-ASP--GLU-352 DEL.",
            "Missing in GM2G1. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.32 \"Three novel beta-hexosaminidase A mutations in obligate carriers of Tay-Sachs disease.\" Tomczak J., Grebner E.E. Hum. Mutat. 4:71-72(1994) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-335 AND 347-ASP--GLU-352 DEL.",
            "V \u2192 M in GM2G1; mild; associated with spinal muscular atrophy. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.36 \"A new mutation in the HEXA gene associated with a spinal muscular atrophy phenotype.\" Navon R., Khosravi R., Korczyn T., Masson M., Sonnino S., Fardeau M., Eymard B., Lefevre N., Turpin J.C., Rondot P. Neurology 45:539-543(1995) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 MET-391.",
            "N \u2192 D.1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.24 \"Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.\" Mules E.H., Hayflick S., Miller C.S., Reynolds L.W., Thomas G.H. Am. J. Hum. Genet. 50:834-841(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 GLY-320 DEL, VARIANTS ASP-399 AND VAL-436. Corresponds to variant rs1800430 [ dbSNP | Ensembl ].",
            "W \u2192 C in GM2G1; infantile; inactive protein. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.22 \"A new point mutation in the beta-hexosaminidase alpha subunit gene responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian patient (a Kpn mutant).\" Tanaka A., Punnett H.H., Suzuki K. Am. J. Hum. Genet. 47:568-574(1990) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 CYS-420. Ref.43 \"Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.\" Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T. J. Hum. Genet. 48:571-574(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499.",
            "I \u2192 V.9 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.1 \"Human beta-hexosaminidase alpha chain: coding sequence and homology with the beta chain.\" Myerowitz R., Piekarz R., Neufeld E.F., Shows T.B., Suzuki K. Proc. Natl. Acad. Sci. U.S.A. 82:7830-7834(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT VAL-436. Ref.2 \"Organization of the gene encoding the human beta-hexosaminidase alpha-chain.\" Proia R.L., Soravia E. J. Biol. Chem. 262:5677-5681(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT VAL-436. Ref.3 \"Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.\" Triggs-Raine B.L., Akerman B.R., Clarke J.T.R., Gravel R.A. Am. J. Hum. Genet. 49:1041-1054(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT VAL-436. Ref.5 Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-436. Ref.6 \"The full-ORF clone resource of the German cDNA consortium.\" Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS PSEUDODEFICIENCY TRP-249 AND VAL-436. Ref.8 \"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).\" The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT VAL-436. Ref.9 \"Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.\" Korneluk R.G., Mahuran D.J., Neote K., Klavins M.H., O'Dowd B.F., Tropak M., Willard H.F., Anderson M.-J., Lowden J.A., Gravel R.A. J. Biol. Chem. 261:8407-8413(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 40-529 (ISOFORM 1), VARIANT VAL-436. Ref.24 \"Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.\" Mules E.H., Hayflick S., Miller C.S., Reynolds L.W., Thomas G.H. Am. J. Hum. Genet. 50:834-841(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 GLY-320 DEL, VARIANTS ASP-399 AND VAL-436. Ref.44 \"Initial characterization of the human central proteome.\" Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] VAL-436, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Corresponds to variant rs1800431 [ dbSNP | Ensembl ].",
            "G \u2192 S in GM2G1; infantile.",
            "G \u2192 R in GM2G1; late infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.40 \"Two novel (1334delC and 1363G to A, G455R) mutations in exon 12 of the beta-hexosaminidase alpha-chain gene in two Portuguese patients.\" Ribeiro M.G., Pinto R.A., Suzuki K., Sa Miranda M.C. Hum. Mutat. 10:359-360(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 ARG-455.",
            "C \u2192 Y in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.33 \"Molecular genetics of Tay-Sachs disease in Japan.\" Tanaka A., Sakazaki H., Murakami H., Isshiki G., Suzuki K. J. Inherit. Metab. Dis. 17:593-600(1994) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 TYR-458 AND GLN-484.",
            "W \u2192 C in GM2G1; subacute. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.42 \"W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis.\" Petroulakis E., Cao Z., Clarke J.T.R., Mahuran D.J., Lee G., Triggs-Raine B. Hum. Mutat. 11:432-442(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 CYS-474.",
            "E \u2192 K in GM2G1; infantile. 2 Publications Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.20 \"A point mutation in the coding sequence of the beta-hexosaminidase alpha gene results in defective processing of the enzyme protein in an unusual GM2-gangliosidosis variant.\" Nakano T., Muscillo M., Ohno K., Hoffman A.J., Suzuki K. J. Neurochem. 51:984-987(1988) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 LYS-482. Ref.39 \"Tay-Sachs disease and HEXA mutations among Moroccan Jews.\" Kaufman M., Grinshpun-Cohen J., Karpati M., Peleg L., Goldman B., Akstein E., Adam A., Navon R. Hum. Mutat. 10:295-300(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 GLN-170; PHE-304 DEL AND LYS-482.",
            "L \u2192 Q in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.33 \"Molecular genetics of Tay-Sachs disease in Japan.\" Tanaka A., Sakazaki H., Murakami H., Isshiki G., Suzuki K. J. Inherit. Metab. Dis. 17:593-600(1994) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 TYR-458 AND GLN-484.",
            "W \u2192 R in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.28 \"Novel Tay-Sachs disease mutations from China.\" Akalin N., Shi H.-P., Vavougios G., Hechtman P., Lo W., Scriver C.R., Mahuran D., Kaplan F. Hum. Mutat. 1:40-46(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GM2G1 ARG-485.",
            "R \u2192 C in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.43 \"Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.\" Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T. J. Hum. Genet. 48:571-574(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499.",
            "R \u2192 H in GM2G1; juvenile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.43 \"Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.\" Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T. J. Hum. Genet. 48:571-574(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499.",
            "R \u2192 C in GM2G1; infantile. 1 Publication Manually curated information for which there is published experimental evidence. More\u2026 Manual assertion based on experiment ini Ref.23 \"Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments.\" Akli S., Lacorte J.-M., Poenaru L., Khan A. Genomics 11:124-134(1991) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GM2G1 PHE-210 AND CYS-504. Corresponds to variant rs28942071 [ dbSNP | Ensembl ].",
            "R \u2192 H in GM2G1; juvenile; inhibited subunit dissociation."
        ],
        [
            "Graphical view",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ],
        [
            "Feature identifier",
            "VAR_003202",
            "VAR_003203",
            "VAR_022439",
            "VAR_003204",
            "VAR_003205",
            "VAR_003206",
            "VAR_003207",
            "VAR_003208",
            "VAR_003209",
            "VAR_003210",
            "VAR_003211",
            "VAR_003212",
            "VAR_003213",
            "VAR_003214",
            "VAR_003215",
            "VAR_003216",
            "VAR_003217",
            "VAR_003218",
            "VAR_022440",
            "VAR_003219",
            "VAR_003220",
            "VAR_003221",
            "VAR_003222",
            "VAR_003223",
            "VAR_017188",
            "VAR_003224",
            "VAR_022441",
            "VAR_003225",
            "VAR_003226",
            "VAR_058477",
            "VAR_017189",
            "VAR_003227",
            "VAR_003228",
            "VAR_022442",
            "VAR_003229",
            "VAR_003230",
            "VAR_003231",
            "VAR_003232",
            "VAR_003233",
            "VAR_003234",
            "VAR_003235",
            "VAR_003236",
            "VAR_003237",
            "VAR_003238",
            "VAR_003239",
            "VAR_003240",
            "VAR_003241",
            "VAR_003242",
            "VAR_003243",
            "VAR_003244",
            "VAR_003245",
            "VAR_003246"
        ],
        [
            "Actions",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
        ]
    ],
    "pageTitle": "HEXA - Beta-hexosaminidase subunit alpha precursor - Homo sapiens (Human)",
    "title": "",
    "url": "http://www.uniprot.org/uniprot/P06865",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988840.31/warc/CC-MAIN-20150728002308-00311-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 813209731,
    "recordOffset": 813127095,
    "tableOrientation": "HORIZONTAL",
    "lastModified": "Wed, 22 Jul 2015 00:00:00 GMT",
    "textBeforeTable": "Natural variant S \u2192 P in BAD96222 (Ref. 5) Curated 1 331\u00a0\u2013\u00a0331 <p>Reports difference(s) between the canonical sequence (displayed by default in the entry) and the different sequence submissions merged in the entry. These various submissions may originate from different sequencing projects, different types of experiments, or different biological samples. Sequence conflicts are usually of unknown origin.</p><p><a href='../manual/conflict' target='_top'>More...</a></p>Sequence conflicti Actions Feature identifier Graphical view Description Length Position(s) Feature key Experimental InfoBLASTProtParamProtScaleCompute pI/MWPeptideMassPeptideCutterGO <p>The checksum is a form of redundancy check that is calculated from the sequence. It is useful for tracking sequence updates.</p> <p>It should be noted that while, in theory, two different sequences could have the same checksum value, the likelihood that this would happen is extremely low.</p> <p>However UniProtKB may contain entries with identical sequences in case of multiple genes (paralogs).</p> <p>The checksum is computed as the sequence 64-bit Cyclic Redundancy Check value (CRC64)",
    "textAfterTable": "Alternative sequence Feature key Position(s) Length Description Graphical view Feature identifier Actions <p>Describes the sequence of naturally occurring alternative protein isoform(s). The changes in the amino acid sequence may be due to alternative splicing, alternative promoter usage, alternative initiation, or ribosomal frameshifting. The information stored in this subsection is used to automatically construct alternative protein sequence(s) for display.</p><p><a href='../manual/var_seq' target='_top'>More...</a></p>Alternative sequencei 1\u00a0\u2013\u00a0192 192 Missing in isoform 2. 1 Publication <p>Manually curated information that is based on statements in scientific articles for which there is no experimental support.</p> <p><a href=\"/manual/evidences#ECO:0000303\">More\u2026</a></p> Manual assertion based on opinion ini Ref.4 \"Complete sequencing and characterization of 21,243 full-length human cDNAs.\" Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}